AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease

RecruitingNAAges 60 Years - 90 YearsAllRuijin Hospital
💬

In plain words

What the trial is, and whether it could suit you

This study is a multicentre, randomized, double-blind, controlled trial that aims to investigate the efficacy of multi-domain life-style intervention including low inflammatory-index diet, exercise, and cognitive training in patients with mild cognitive impairment and mild Alzheimer's disease.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. Aged 60-90 years 2. In accordance with the diagnostic criteria for "mild cognitive impairment due to Alzheimer's disease" or "mild Alzheimer's disease" from the National Institutes of Health National Institute on Aging-Alzheimer's Association (NIA-AA) (2011) 3. The Hamilton depression rating scale/17 edition (HAMD) total score≤10 4. Neurological examination: no obvious signs 5. Education: primary school (grade 6) or above and capacity to complete tests for cognitive ability 6. Capacity to give consent Exclusion Criteria: 1. Other causes of cognitive decline: cerebrovascular disease, central nervous system infection, Creutzfeldt-Jakob disease, Huntington's and Parkinson's disease, Creutzfeldt-Jakob disease, traumatic brain dementia, other physical and chemical factors (such as drugs, alcohol, CO), systemic disease (hepatic encephalopathy, pulmonary encephalopathy, etc.), intracranial occupation (a subdural hematoma, brain tumor), the endocrine system disease (thyroid disease, parathyroid disease), and vitamins deficiency or any other causes of dementia 2. The history of nervous system diseases, including stroke, optic myelitis, Parkinson's disease, epilepsy, etc 3. Psychiatric patients, including schizophrenia or other mental illnesses, bipolar disorder, major depression, or delirium 4. There are unstable or serious heart, lung, liver, kidney, endocrine, and hematopoietic system diseases, or Poor prognosis because of malignant diseases such as tumors. 5. Vision or hearing problems that lead to poor performance on cognitive tests 6. Two years history of severe alcoholism, and drug abuse 7. Participants who participated in any other trial 30 days prior to their screening visit 8. Contraindication of MRI scanning 9. Special requirements for diet, e.g., allergy to common food or on a special diet due to medical needs 10. Participants who cannot be followed for at least 6 months (due to a health situation or migration)
💊

What it tests

  • Diet intervention
  • Exercise
  • Cognitive training
📍

Where

1 site
Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy